Restriction of human herpesvirus 6B replication by p53

J Gen Virol. 2008 May;89(Pt 5):1106-1113. doi: 10.1099/vir.0.83262-0.

Abstract

Human herpesvirus 6B (HHV-6B) induces significant accumulation of p53 in both the nucleus and cytoplasm during infection. Activation of p53 by DNA damage is known to induce either growth arrest or apoptosis; nevertheless, HHV-6B-infected cells are arrested in their cell cycle independently of p53, and only a minor fraction of the infected cells undergoes apoptosis. Using pifithrin-alpha, a p53 inhibitor, and p53-null cells, this study showed that infected epithelial cells accumulated viral transcripts and proteins to a significantly higher degree in the absence of active p53. Moreover, HHV-6B-induced cytopathic effects were greatly enhanced in the absence of p53. This suggests that, in epithelial cells, some of the functions of p53 leading to cell-cycle arrest and apoptosis are restrained by HHV-6B infection, whereas other cellular defences, causing inhibition of virus transcription, are partially retained.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzothiazoles / pharmacology
  • Cell Line
  • Cytopathogenic Effect, Viral
  • Enzyme Inhibitors / pharmacology
  • Epithelial Cells / virology
  • Herpesvirus 6, Human / immunology*
  • Humans
  • Toluene / analogs & derivatives
  • Toluene / pharmacology
  • Tumor Suppressor Protein p53 / antagonists & inhibitors
  • Tumor Suppressor Protein p53 / deficiency
  • Tumor Suppressor Protein p53 / physiology*
  • Virus Replication / immunology*

Substances

  • Benzothiazoles
  • Enzyme Inhibitors
  • Tumor Suppressor Protein p53
  • Toluene
  • pifithrin